Skip to main content

Advertisement

SpringerLink
Log in

Epstein-Barr viral antigens used in the diagnosis of nasopharyngeal carcinoma

  • Review
  • Published:
Journal of Biomedical Science

Abstract

The major antigen complexes of Epstein-Barr virus (EBV) include the latent infectious proteins, early antigens, membrane antigens and viral capsid antigens. The various polypeptides within each antigen complex have been identified and isolated through gene-cloning technology. These polypeptides are exploited to be used as serological markers for the diagnosis of nasopharyngeal carcinoma (NPC) through enzyme-linked immunosorbent assay. This paper reviews the recent studies on the profile of antibodies in patients with NPC towards these EBV polypeptides of each antigen complex. The sensitivity and specificity of each polypeptide when used as serological markers to NPC patients' sera are summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baylis SA, Purifoy DJM, Littler E. High level expression of the Epstein-Barr virus alkaline deoxyribonuclease using a recombinant baculovirus: Application to the diagnosis of nasopharyngeal carcinoma. Virology 181:390–394;1991.

    Article  PubMed  Google Scholar 

  2. Chen HF, Sauter M, Haiss P, Muller LN. Immunological characterization of the Epstein-Barr virus phosphoprotein PP58 and deoxyribonuclease expressed in the baculovirus expression system. Int J Cancer 48:879–888;1991.

    PubMed  Google Scholar 

  3. Chen HF, Kevan-Jah S, Suentzenich KO, Grasser FA, Mueller-Lantzsch N. Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera gainst this protein. Virology 190:106–115;1992.

    Article  PubMed  Google Scholar 

  4. Chen JY, Liu MY, Hsu TY, Cho SM, Yang CS. Use of bacterially expressed antigen for detection of antibodies to the EBV-specific deoxyribonuclease in sera from patients with nasopharyngeal carcinoma. J Virol Methods 45:49–66;1993.

    Article  PubMed  Google Scholar 

  5. Cheng HM, Foong YT, Mathew A, Sam CK, Dillner J, Prasad U. Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay. J Virol Methods 42:45–51;1993.

    Article  PubMed  Google Scholar 

  6. Cheng YC. Frequency and levels of antibodies to Epstein-Barr virus-specific DNAse are elevated in patients with nasopharyngeal carcinoma. Proc Natl Acad Sci 77:6162–6165;1980.

    PubMed  Google Scholar 

  7. Durda PJ, Sullivan M, Kieff E, Pearson GR, Rabin H. An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen. Intervirology 36:11–19;1993.

    PubMed  Google Scholar 

  8. Fones-Tan A, Chan SH, Tsao SY, Gan LH, Tan WH, Li B, Khong PW, Gan YY. Enzymelinked immunosorbent assay (ELISA) for IgA and IgG antibodies to Epstein-Barr virus ribonucleotide reductase in patients with nasopharyngeal carcinoma. Int J Cancer 59:739–742;1994.

    PubMed  Google Scholar 

  9. Foong YT, Cheng HM, Sam CK, Dillner J, Hinderer W, Prasad U. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma. Int J Cancer 45:1061–1064;1990.

    PubMed  Google Scholar 

  10. Frech B, Zimber-Strobl U, Yip TTC, Lau WH, Müller-Lantzsch N. Characterization of the antibody response to the latent infection terminal proteins of Epstein-Barr virus in patients with nasopharyngeal carcinoma. J Gen Virol 74:811–818;1993.

    PubMed  Google Scholar 

  11. Gan YY, Fones-Tan A, Chan SH, Tsao SY, Li B. Molecular cloning and expression of Epstein-Barr virus antigens in the lambda gt11 expression vector: antibodies towards proteins from the BORF2 and BKRF4 reading frames in NPC patients. Intervirology 37:233–235;1994.

    PubMed  Google Scholar 

  12. Ginsburg M. Antibodies against the large subunit of the EBV-encoded ribonucleotide reductase in patients with nasopharyngeal carcinoma. Int J Cancer 45:1048–1053;1990.

    PubMed  Google Scholar 

  13. Gorgievski-Hrisoho M, Hinderer W, Nebel-Schickel H, et al. Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. J Clin Microbiol 28:2305–2311;1990.

    PubMed  Google Scholar 

  14. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1–7;1976.

    PubMed  Google Scholar 

  15. Henle W, Henle G, Lennette ET. The Epstein-Barr virus. Sci Am 241:48–59;1979.

    PubMed  Google Scholar 

  16. Hille A, Klein K, Baumler S, Grasser FA, Müller-Lantzsch N. Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins. J Med Virol 39:233–241;1993.

    PubMed  Google Scholar 

  17. Inoue N, Kuranari J, Harada S, Nakajima H, Ohbayashi M, Nakamura Y, Miyasaka N, Ezawa K, Ban F, Yanagi K. Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1. J Clin Microbiol 30:1442–1448;1992.

    PubMed  Google Scholar 

  18. Joab I, Nicolas JC, Schwaab G, et al. Detection of anti-Epstein-Barr virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 48:647–649;1991.

    PubMed  Google Scholar 

  19. Littler E, Newman W, Arrand JR. Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr-virus-coded thymidine kinase expressed inE. coli. Int J Cancer 45:1028–1032;1990.

    PubMed  Google Scholar 

  20. Littler E, Baylis SA, Zeng Y, Conway MJ, Mackett M, Arrand JR. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins. Lancet 337:685–689;1991.

    Article  PubMed  Google Scholar 

  21. Liu MY, Chou WH, Nutter L, Hsu MM, Chen JY, Yang CS. Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma. J Med Virol 28:101–105;1989.

    PubMed  Google Scholar 

  22. Lenette ET, Rymo L, Yadav M, et al. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Eur J Cancer 29A:1584–1589;1993.

    Article  PubMed  Google Scholar 

  23. Mathew M, Cheng HM, Sam CK, Joab I, Prasad U, Cochet C. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol Immunother 38:68–70;1994.

    PubMed  Google Scholar 

  24. Ooka T, Turenne M, Stolzenberg MC. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Springer Semin in Immunopathol 13:233–247;1991.

    Google Scholar 

  25. Pearson GR, Luka J, Petti L, et al. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. J Virol 160:151–161;1987.

    Article  Google Scholar 

  26. Pothen S, Cao T, Smith R, Levine PH, Levine A, Pearson GR. Identification of T- and B-cell epitopes associated with a restricted component of the Epstein-Barr virus-induced early antigen complex. Int J Cancer 53:199–204;1993.

    PubMed  Google Scholar 

  27. Rowe M, Finke J, Szigeti R, Klein G. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. J Gen Virol 69:1217–1228;1988.

    PubMed  Google Scholar 

  28. Sigel G, Schillinger M, Henninger K, Bauer G. IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of baculovirus nasopharyngeal carcinoma. J Med Virol 43:222–227;1994.

    PubMed  Google Scholar 

  29. Tan RS, Li JS, Grill SP, Nutter LM, Cheng YC. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Cancer Res 46:5024–5028;1986.

    PubMed  Google Scholar 

  30. Turenne-Tessier MD, Ooka T, Calender A, De The G, Daillie J. Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus specific thymidine kinase. Int J Cancer 43:45–48;1989.

    PubMed  Google Scholar 

  31. Uen WC, Luka J, Pearson GR. Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus. Int J Cancer 41:479–482;1988.

    PubMed  Google Scholar 

  32. Van Grunsven WMJ, Spaan WJM, Middel-dorp JM. Localization and diagnostic application of immunodominant domains of the BKRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis 170:13–19;1994.

    PubMed  Google Scholar 

  33. Vroman B, Luka J, Rodriguez M, Pearson GR. Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus. J Virol 53:107–113;1985.

    PubMed  Google Scholar 

  34. Yao QY, Rowe M, Morgan AJ, et al. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization. Int J Cancer 48:45–50;1991.

    PubMed  Google Scholar 

  35. Zhu XX, Zeng Y, Wolf H. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals. Int J Cancer 37:689–691;1986.

    PubMed  Google Scholar 

  36. Zeng Y. Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 44:121–138;1985.

    PubMed  Google Scholar 

  37. Zeng Y, Wolf H, Tadaka K, Arrand JR, De The G. Detection of EBV specific IgA antibodies to Ea, MA and EBNA-1 recombinant proteins in NPC patients and controls. In: Ablashi DV, Faggioni A, Krueger GRF, Pagano JS, Pearson GR (eds): Epstein-Barr virus and human diseases. Humana Press, Clifton, pp 309–313.

Download references

Author information

Authors and Affiliations

  1. National University of Singapore, WHO Immunology Centre, Singapore

    S. H. Chan

  2. School of Science NIE, Nanyang Technological University, 469, Bukit Timah Road, 259756, Singapore

    Y. Y. Gan, A. Fones-Tan & L. H. Gan

Authors
  1. Y. Y. Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Fones-Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. H. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. H. Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gan, Y.Y., Fones-Tan, A., Chan, S.H. et al. Epstein-Barr viral antigens used in the diagnosis of nasopharyngeal carcinoma. J Biomed Sci 3, 159–169 (1996). https://doi.org/10.1007/BF02253096

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02253096

Key Words

Search

Navigation